Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Mapk8em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Mapk8em1/Cya

Common Name
Mapk8-KO
Product ID
S-KO-08501
Backgroud
C57BL/6JCya
Strain ID
KOCMP-26419-Mapk8-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Mapk8-KO Mouse (Catalog S-KO-08501) were purchased from Cyagen.”
KO Models
Wnt signaling pathway
ErbB signaling pathway
MAPK signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Wnt signaling pathway
ErbB signaling pathway
MAPK signaling pathway
Basic Information
Strain Name
Mapk8-KO
Strain ID
KOCMP-26419-Mapk8-B6J-VA
Gene Name
Mapk8
Product ID
S-KO-08501
Gene Alias
JNK, JNK1, Prkm8, SAPK1
Background
C57BL/6JCya
NCBI ID
26419 (Mouse)
Modification
Conventional knockout
Chromosome
Chr 14 (Mouse)
Phenotype
MGI:1346861
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000111945
NCBI Transcript ID
NM_016700
Target Region
Exon 3~7
Size of Effective Region
~18.4 kb
Overview of Gene Research
Mapk8, also known as Mitogen-activated protein kinase 8, is involved in multiple cellular signaling pathways. It is a key component in the c-Jun N-terminal kinase (JNK) signaling pathway, which plays crucial roles in regulating cell proliferation, differentiation, apoptosis, and immune response [2,3,4]. Dysregulation of Mapk8 can lead to various diseases as it is associated with pathways like PI3K-Akt and MAPK signaling, which are important in cell survival and growth [5,6,7]. Genetic models such as gene knockout in mice can be valuable for studying its functions in vivo.

In intervertebral disc degeneration (IDD), Mapk8 was identified as a key biomarker. Analysis of gene expression profiles in IDD showed that Mapk8, along with other genes, was involved in autophagy-related pathways. In a rat IDD model, qPCR validation confirmed that Mapk8 was consistent with bioinformatic analysis results, suggesting it could be a potential therapeutic target for IDD [1]. In chicken male germ cell differentiation, knockdown/overexpression of Mapk8 affected the differentiation of embryonic stem cells into spermatogonial stem cells by inhibiting/activating the JNK signal [3]. In glioblastoma cells resistant to temozolomide, Mapk8 was up-regulated, and its inhibition restrained colony formation and induced apoptosis of these cells by suppressing the MAPK signaling pathway [6].

In conclusion, Mapk8 is essential in multiple biological processes and diseases. Through model-based research, especially in conditions like IDD, male germ cell differentiation, and glioblastoma, it has been shown to play significant roles. The study of Mapk8 in KO/CKO mouse models could further enhance our understanding of its functions and potentially lead to new therapeutic strategies for related diseases.

References:
1. Zhang, Yuxin, Zhang, Jiahui, Sun, Zhongyi, Xi, Xiaobing, Tian, Jiwei. 2023. MAPK8 and CAPN1 as potential biomarkers of intervertebral disc degeneration overlapping immune infiltration, autophagy, and ceRNA. In Frontiers in immunology, 14, 1188774. doi:10.3389/fimmu.2023.1188774. https://pubmed.ncbi.nlm.nih.gov/37325630/
2. Wang, Shuai, Deng, Zhantao, Ma, Yuanchen, Lyu, Feng-Juan, Zheng, Qiujian. 2020. The Role of Autophagy and Mitophagy in Bone Metabolic Disorders. In International journal of biological sciences, 16, 2675-2691. doi:10.7150/ijbs.46627. https://pubmed.ncbi.nlm.nih.gov/32792864/
3. Wang, Yingjie, Bi, Yulin, Zuo, Qisheng, Zhang, Ya-Ni, Li, Bichun. 2017. MAPK8 regulates chicken male germ cell differentiation through JNK signaling pathway. In Journal of cellular biochemistry, 119, 1548-1557. doi:10.1002/jcb.26314. https://pubmed.ncbi.nlm.nih.gov/28815778/
4. Li, Jian, Tian, Mouli, Hua, Tong, Zhang, Xiaoping, Yuan, Hongbin. 2021. Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain. In Autophagy, 17, 4062-4082. doi:10.1080/15548627.2021.1900498. https://pubmed.ncbi.nlm.nih.gov/33834930/
5. Aihaiti, Yirixiati, Song Cai, Yong, Tuerhong, Xiadiye, Xu, Ke, Xu, Peng. 2021. Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation. In Frontiers in pharmacology, 12, 672054. doi:10.3389/fphar.2021.672054. https://pubmed.ncbi.nlm.nih.gov/34054546/
6. Xu, Peng, Zhang, Guofeng, Hou, Shuangxing, Sha, Long-Gui. 2018. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 106, 1419-1427. doi:10.1016/j.biopha.2018.06.084. https://pubmed.ncbi.nlm.nih.gov/30119215/
7. Ge, Bingjie, Yan, Kexin, Sang, Rui, Qiu, Qian, Zhang, Xuemei. 2024. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity. In Ecotoxicology and environmental safety, 275, 116278. doi:10.1016/j.ecoenv.2024.116278. https://pubmed.ncbi.nlm.nih.gov/38564860/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research